Ahealthtechsitethatspeakstocliniciansandinvestorsatonce

Two things: the dual-audience problem and the compliance surface area. A typical B2B startup site talks to one buyer type. A healthtech site has to address clinical procurement and investor due diligence simultaneously, with different trust signals for each. On top of that, the moment any page touches patient-identifiable data or intake workflows, HIPAA boundaries apply. That combination of audience complexity and regulatory awareness is what makes healthtech design its own discipline.

Yes, in factual language. Statements like 'FDA 510(k) submission in progress,' 'CE mark expected Q3,' or 'HIPAA-aware data handling' are accurate and appropriate. What the site cannot do is make efficacy claims unsupported by published evidence. I build the content structure for claims and disclosures; your regulatory or QA advisor approves the exact wording. Most healthtech founders already have a QA/RA contact. I work with them directly and typically land final copy in under two review rounds.

Usually not, because a standard marketing site collects only name, email, and a general inquiry. The boundary breaks down when intake forms ask patients to describe symptoms, upload records, or request a clinical service. I build that boundary explicitly: the marketing site stays light, and any clinical intake routes through a HIPAA-compliant vendor with a signed BAA. The privacy policy documents exactly where that line sits so health system partners have a written answer when they ask.

Three to five weeks for the Starter and Business tiers. The variable is content readiness and clinical review cycles. If your clinical co-founder needs two rounds of review on the evidence page, budget an extra week. I flag that dependency in the kickoff document so it doesn't arrive as a surprise. If you have a hard fundraising deadline, a focused launch page can be ready in two weeks while the full site finishes in parallel.

I default to Next.js with Sanity or Payload. Both are structured-content systems that let non-developers publish studies, publications, press items, and product updates through a form rather than code. The schemas enforce consistency so a clinical program manager can add a new study at midnight and it looks identical to every other study on the site. Headless CMS also means the content is owned by your team and portable if you ever change front-end stacks.

When you have real users who need a self-serve experience inside the product itself. A marketing site carries the message until you're ready to build. A product portal is Applications scope at $4,999 a month, not a fixed-price website project. Most healthtech founders ship the marketing site first, raise on it, then move to an Applications subscription once there's budget and a defined product roadmap. That sequencing avoids a large portal investment before product-market fit is confirmed.